Cancer deaths in the US are falling, and there are more survivors than ever

Read Time:7 Minute, 58 Second

More people are surviving in the United States than ever before, according to a new report from the American Association for Cancer Research. diagnosis — increased by more than a million. As of January, there were 18 million survivors in the U.S., and that number is expected to increase to 26 million by 2040, according to the association. The report notes that in 1971 there were only 3 million cancer survivors in the United States. For all cancers combined, the five-year overall survival rate increased from 49% in the mid-1970s to nearly 70% from 2011 to 2017, the most recent years for which data are available. Age-adjusted overall cancer death rates continue to decline, with the decline between 1991 and 2019 resulted in nearly 3.5 million deaths being avoided, the association said.Smoking reductions and improvements in early cancer detection and treatment are contributing to the change, according to the AACR Cancer Progress Report 2022 released Wednesday. year Lisa Cousens, the association’s president, said in a statement that part of the credit goes to investing in research — both for treatment and for understanding the disease. fundamental discoveries in fundamental science,” she said. “Investment in cancer science, as well as support for science education at all levels, is absolutely essential to advance the next wave of discoveries and accelerate progress.” For example, from Aug. 1 to July 31, the U.S. Food and Drug Administration approved eight cancer therapeutics, expanded the use of 10 previously approved drugs to treat new cancers and approved two diagnostic imaging tools, Cousens said at a news conference Wednesday. Increasing funding for cancer research is a cornerstone of President Joe Biden’s reinvigorated Cancer Moonshot initiative. Biden, who lost a son to brain cancer, said this month that his goal is to cut cancer deaths in the United States by at least half in the next 25 years. “Cancer does not distinguish between red and blue. He doesn’t care. if you are a republican or a democrat. Defeating cancer is something we can do together,” said Biden, who originally spearheaded the initiative when he was vice president under Obama. The new report calls on Congress to fully fund and support Biden’s goal “to end cancer as we know it “. “The renewed Cancer Moonshot will provide an important basis for improving cancer prevention strategies; increase screening and early detection of cancer; reduce cancer disparities; and lead to new life-saving drugs for cancer patients,” the report said, adding that “the actions will transform cancer care , will increase survival rates and bring life-saving medicines to millions of people whose lives have been touched by cancer.” With deaths averted between 1991 and 2019, more than 600,000 people in the U.S. are still expected to die from cancer this year, according to “In the United States alone, the number of new cancer cases diagnosed each year is expected to reach nearly 2.3 million by 2040,” according to the association. – says the report. About 40% of cancers in the U.S. are attributable to preventable risk factors, such as smoking, excessive alcohol consumption, poor diet, insufficient physical activity and obesity, according to the report. But there are also persistent problems, such as health disparities that affect racial and ethnic minorities, and barriers to health care such as limited health insurance and living in rural areas. In a statement at a news conference, U.S. Rep. Nickema Williams said that after her mother’s death from cancer, she learned that “ health care in America is not yet a human right.” “There are two health care systems in this country: one for people who can afford preventive services and quality treatment, and one for everyone else,” said Williams, a Democrat from Georgia. Overturning Roe v. Wade is also expected to affect cancer care. treatment, limiting health care options for pregnant women with cancer, the report said. said: “With the recent Supreme Court decision overturning Roe v. Wade, which ended the constitutional right to abortion, there is uncertainty surrounding how specific cancer treatments may lead to before termination of pregnancy. Such uncertainty may prevent some physicians from prescribing medications or providing other health care services in a timely manner because of the potential legal consequences for both the physician and the mother,” the report said. The COVID-19 pandemic has affected cancer in the US, with nearly 10 million missed screenings for breast, rectal and prostate cancer in 2020. The report makes recommendations for building on progress and restoring momentum. “Progress in the fight against cancer means more birthdays, more Christmases, more graduations and more everyday moments for families everywhere,” Williams said.

More people are surviving cancer in the United States than ever before, according to a new report from the American Association for Cancer Research.

In the past three years, the number of cancer survivors in the U.S. — defined as people alive who have been diagnosed with cancer — has increased by more than a million. As of January, there were 18 million survivors in the U.S., and that number is expected to increase to 26 million by 2040, according to the association. The report notes that in 1971 there were only 3 million cancer survivors in the US.

For all cancers combined, the five-year overall survival rate rose from 49% in the mid-1970s to nearly 70% from 2011 to 2017, the most recent years for which data are available.

The overall age-adjusted death rate from cancer continues to decline, and the decline between 1991 and 2019 resulted in nearly 3.5 million deaths being avoided, the association said.

A reduction in smoking and improvements in early detection and treatment of cancer are driving change, according to the AACR Cancer Progress Report 2022released on Wednesday.

Dr. Lisa Cousens, president of the association, said in a statement part of the credit goes to investment in research – both for treatment and for understanding the disease.

“Targeted therapy, immunotherapy and other new therapeutic approaches that are being used in clinical practice all stem from fundamental discoveries in basic science,” she said. “Investment in cancer science, as well as support for science education at all levels, is absolutely essential for the next wave of discoveries and to accelerate progress.”

For example, between Aug. 1 and July 31, the U.S. Food and Drug Administration approved eight cancer therapeutics, expanded the use of 10 previously approved drugs to treat new cancers and approved two diagnostic imaging tools, Cousens said at a news conference Wednesday. . .

Increasing funding for cancer research is a cornerstone of President Joe Biden’s renewed Cancer Moonshot initiative.

Biden, who lost a son to brain cancer, said this month that his goal is to cut cancer deaths in the United States by at least half in the next 25 years.

“Cancer does not distinguish between red and blue. It doesn’t matter if you’re a Republican or a Democrat. Defeating cancer is something we can do together,” said Biden, who originally spearheaded the initiative when he was vice president under Obama.

A new report calls on Congress to fully fund and support Biden’s goal to “end cancer as we know it.”

“The Reignited Cancer Moonshot will provide an important foundation for improving cancer prevention strategies; expanding screening and early detection of cancer; reducing differences in cancer; and creating new life-saving drugs for cancer patients,” the report says, adding that “actions will transform cancer care, increasing survival rates and accepting life-saving drugs for millions of people whose lives have been touched by cancer.”

Although nearly 3.5 million cancer deaths were avoided between 1991 and 2019, more than 600,000 people in the U.S. are expected to die from cancer this year, according to the association.

“In the United States alone, the number of new cancer cases diagnosed each year is expected to reach nearly 2.3 million by 2040,” the report said.

According to the report, about 40% of cancers in the US are attributable to preventable risk factors such as smoking, excessive alcohol consumption, poor diet, lack of exercise and obesity.

But there are also persistent challenges, such as health disparities that affect racial and ethnic minorities, and barriers to health care, such as limited health insurance and living in rural areas.

In a taped statement at a news conference, U.S. Rep. Nickema Williams said she learned after her mother’s death from cancer that “healthcare in America is not yet a human right.”

“We have two health care systems in this country: one for people who can afford preventive services and quality treatment, and one for everyone else,” said Williams, D-Georgia.

Overturning Roe v. Wade is also expected to affect cancer treatment, limiting health care options for pregnant women with cancer, the report said.

“With the Supreme Court’s recent decision overturning Roe v. Wade, ending the constitutional right to abortion, there is uncertainty about how specific cancer treatments can lead to termination of pregnancy. Such uncertainty may prevent some doctors from prescribing drugs or providing other health care services in a timely manner because of the potential legal consequences for both the doctor and the mother,” the report said.

The COVID-19 pandemic has affected cancer in the US, with nearly 10 million missed screenings for breast, colorectal and prostate cancer in 2020.

The report provides recommendations for building on progress and restoring momentum.

“Making progress in the fight against cancer means more birthdays, more Christmases, more graduations and more everyday moments for families around the world,” Williams said.

Source by [author_name]

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Opinion: San Diego needs an ambulance service it can count on
Next post Hydrogen could power new passenger trains through Altamont